Results for tag: "Tourette Syndrome Drug"

Tourette Syndrome (TS) is a neurological disorder characterized by involuntary, repetitive movements and vocalizations known as tics. It is estimated to affect 1 in every 160 children in the United States. Treatment for TS typically involves a combination of medications and behavioral therapy. The Tourette Syndrome Drug market is a subset of the Central Nervous System (CNS) Drugs market. CNS drugs are used to treat a variety of neurological disorders, including TS. These drugs are typically prescribed to reduce the severity of tics and other symptoms associated with TS. Commonly prescribed drugs for TS include antipsychotics, anticonvulsants, and alpha-2 agonists. The Tourette Syndrome Drug market is highly competitive, with a number of large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, Novartis, GlaxoSmithKline, and Johnson & Johnson. Show Less Read more